Video-assisted thoracoscopic surgery for lung cancer in patients on hemodialysis.
Klíčová slova
Abstraktní
OBJECTIVE
Surgical treatment of lung cancer in patients receiving hemodialysis carries a high risk because of poor cardiac function and a fragile electrolyte balance. Because the number of patients receiving hemodialysis has increased, the proportion of such patients with lung cancer is expected to rise. However, few studies have examined the results of surgery for lung cancer in hemodialysis patients, especially by video-assisted thoracoscopic surgery (VATS).
METHODS
We conducted a retrospective analysis of 5 hemodialysis patients who underwent VATS for lung cancer.
RESULTS
All patients were men, and the mean age was 70.4 years. The operative procedure was lobectomy in 4 patients and segmentectomy in 1. During the perioperative period, none required urgent hemodialysis. There were no critical complications and in-hospital deaths. Three of the 5 patients are currently alive and recurrence-free. One patient died of recurrence at 4 month after surgery, and the other patient died at 17 months after surgery without cancer recurrence.
CONCLUSIONS
VATS appears to be a safe procedure for hemodialysis patients with lung cancer, and the long-term outcome is satisfactory.
